Clinical Trials Browser

Phase 1 × OTHER × Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 × Clear all

NCT04522336 2026-03-05

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

Phase 1 Active not recruiting

Gastrointestinal

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8